Improving access to venture capital for life science entrepreneurs and emerging biopharma companies in the BioHealth Capital Region (BHCR) is a top priority. However, elevating the region’s funding profile is not the only type of access undergoing a transformation in recent years.
Image: https://biobuzz.io
There’s an old joke about economists that I’ve always liked. A junior professor goes to his senior colleague with a brilliant new idea. The older man dismisses it. “That may be fine in practice,” he sniffs, “but it will never work in theory.”
Economists are like that, at least many of them. They don’t like to have reality intrude on their abstractions. One of the best examples has to do with mobility. Years ago, I read an article by a prominent economist downplaying the problem of a small-town factory that spews out pollution. What’s the big deal, he asked. There must be another town nearby without a soot-belching factory. The residents of the first town could just move over there. Pretty soon the polluter would get the idea.
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little about themselves, their work, and maybe something completely unrelated. March is WOMEN’S HISTORY MONTH and BioBuzz will celebrate by featuring Women in the BioHealth industry all month, especially in “5 Questions With…”. This week we continue the series with Destinie Burgan, Upstream Supervisor of Manufacturing, Emergent BioSolutions.
Image: https://biobuzz.io
The program, first conceived in 2016, puts the Charlottesville institution in Greater Washington and creates a new talent pool for the Falls Church-based organization.
Image: The Claude Moore Health Education and Research Center, part of the Inova Fairfax Medical Campus, houses medical school classrooms and offices for curriculum, student affairs and faculty affairs. COURTESY INOVA HEALTH SYSTEM
Astrategic alliance has a new name — Verge — and a new vision of acting as the front door for an innovation economy that stretches from Lynchburg to the New River Valley.
Formed last year, the alliance is a joint mission of the Valleys Innovation Council, the Roanoke-Blacksburg Technology Council and the Regional Accelerator and Mentoring Program, known as RAMP.
At a virtual news conference Monday, organizers said the unified strength of the three organizations will help solidify connections and better leverage emerging opportunities for the region’s technologists, innovators and entrepreneurs.
A Rockville, Maryland-based startup bringing AI and computer vision tools to pediatric health received nearly $1 million for R&D in a grant from the National Science Foundation.
The Phase II Small Business Innovation Research award, which is for $982,500, will help Pediametrix as it continues to develop SoftSpot, a digital cranial measurement tool.
PediaMetrix was founded in 2018 by Dr. Fereshteh Aalamifar, who earned her Ph.D. at Baltimore’s Johns Hopkins University, and a group of scientists and entrepreneurs who are alumni of Johns Hopkins, Harvard University and Princeton University.
Image: Dr. Fereshteh Aalamifar is CEO of PediaMetrix. (Courtesy photo)
Partnering meeting slots now are full with more than 450 1:1 partnering meetings requested with Program Officers from NSF, NIH and its individual institutes (NCI, NIA, NIAID, NIDA, NHLBI) and the University of Maryland MIPS. Do not miss the opportunity to hear from these program leaders. Learn how to write compelling Research Aims and Commercialization Plans, current areas of focus for nondilutive funding resources, additional government resources, and best industry strategies to support your firm’s growth. Confirmed speakers/partnering meeting participants include:
Register (no fee) today! www.tinyurl.com/2021SBIR Questions: BHI@BioHealthInnovation.org
NOTE: Different institutes are available to meet at different times during the March 17-19th period.
You will be able to request meetings once you have registered and received the partnering log-in.
Are you a biohealth company with innovative technology seeking funds to advance your commercialization activities? Do not miss a unique opportunity to discuss your innovation research and commercialization plans directly with Program Officers from NSF, NIH and its individual institutes (NCI, NIA, NIAID, NIDA, NHLBI) and the University of Maryland MIPS. Learn how to write compelling Research Aims and Commercialization Plans, current areas of focus for nondilutive funding resources, additional government resources, and best industry strategies to support your firm’s growth. Confirmed speakers/partnering meeting participants include:
Register (no fee) today! www.tinyurl.com/2021SBIR Questions: BHI@BioHealthInnovation.org
NOTE: Different institutes are available to meet at different times during the March 17-19th period.
You will be able to request meetings once you have registered and received the partnering log-in.
More than 160 entrepreneurs attended last week’s BHI Virtual Non-Dilutive Funding Workshop with 1:1 Partnering cohosted by BioHealth Innovation and Montgomery County Economic Development Corporation (MCEDC). Attendees learned about funding opportunities, resources and best practices from program officers at NIH, NSF and the University of Maryland, and also about additional resources and tips for winning applications from experts at MCEDC, the City of Gaithersburg, Maryland Department of Commerce, and BioHealth Innovation. More than 460 partnering meetings were requested. Many took place during the event last week, and others will happen in the near future. Most of the panelists have agreed to share their presentations and panel recordings. These will be available through BHI within the next two weeks. BHI would like to thank the participants who took the time to prepare, present, and/or partner at the event. They include:
Register (no fee) today! www.tinyurl.com/2021SBIR Questions: BHI@BioHealthInnovation.org
NOTE: Different institutes are available to meet at different times during the March 17-19th period.
You will be able to request meetings once you have registered and received the partnering log-in.
Dr. Dipanjan Pan and Phil Robilotto of the University of Maryland, Baltimore, join BioTalk to discuss RNA Disease Diagnostics, UM Ventures, and the commercialization of new medical technologies
Listen via Apple http://apple.co/3bsUsda, Google http://bit.ly/38l26Vd , Spotify http://spoti.fi/38kp9zu, and TuneIN http://bit.ly/2MVFqDp.
